Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
0.9260
-0.0040 (-0.43%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Myomo Revenue
Myomo had revenue of $9.65M in the quarter ending June 30, 2025, with 28.34% growth. This brings the company's revenue in the last twelve months to $40.76M, up 93.07% year-over-year. In the year 2024, Myomo had annual revenue of $32.55M with 69.17% growth.
Revenue (ttm)
$40.76M
Revenue Growth
+93.07%
P/S Ratio
0.86
Revenue / Employee
$220,325
Employees
185
Market Cap
35.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
| Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
| Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
| Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
| Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
MYO News
- 2 months ago - Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 2 months ago - Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Myomo Reports Second Quarter 2025 Financial and Operating Results - Business Wire
- 3 months ago - Myomo to Report Second Quarter 2025 Financial Results on August 11 - Business Wire
- 4 months ago - Myomo Provides Highlights of Today's Investor & Analyst Day Event - Business Wire
- 6 months ago - Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Myomo Reports First Quarter 2025 Financial and Operating Results - Business Wire
- 6 months ago - Myomo to Host Investor & Analyst Day Event on June 18, 2025 - Business Wire